183 related articles for article (PubMed ID: 35142102)
1. Neuropathological lesions and their contribution to dementia and cognitive impairment in a heterogeneous clinical population.
Godrich D; Martin ER; Schellenberg G; Pericak-Vance MA; Cuccaro M; Scott WK; Kukull W; Montine T; Beecham GW
Alzheimers Dement; 2022 Dec; 18(12):2403-2412. PubMed ID: 35142102
[TBL] [Abstract][Full Text] [Related]
2. Clinico-Neuropathological Findings in the Oldest Old from the Georgia Centenarian Study.
Tanprasertsuk J; Johnson EJ; Johnson MA; Poon LW; Nelson PT; Davey A; Martin P; Barbey AK; Barger K; Wang XD; Scott TM
J Alzheimers Dis; 2019; 70(1):35-49. PubMed ID: 31177211
[TBL] [Abstract][Full Text] [Related]
3. The Contribution of Cerebral Vascular Neuropathology to Mild Stage of Alzheimer's Dementia Using the NACC Database.
Liu Y; Chan DK; Crawford JD; Sachdev PS; Braidy N
Curr Alzheimer Res; 2020; 17(13):1167-1176. PubMed ID: 33583381
[TBL] [Abstract][Full Text] [Related]
4. Neuropathologic basis of age-associated brain atrophy.
Erten-Lyons D; Dodge HH; Woltjer R; Silbert LC; Howieson DB; Kramer P; Kaye JA
JAMA Neurol; 2013 May; 70(5):616-22. PubMed ID: 23552688
[TBL] [Abstract][Full Text] [Related]
5. Neuropathological lesions in the very old: results from a large Brazilian autopsy study.
Suemoto CK; Leite REP; Ferretti-Rebustini REL; Rodriguez RD; Nitrini R; Pasqualucci CA; Jacob-Filho W; Grinberg LT
Brain Pathol; 2019 Nov; 29(6):771-781. PubMed ID: 30861605
[TBL] [Abstract][Full Text] [Related]
6. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
[TBL] [Abstract][Full Text] [Related]
7. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
[TBL] [Abstract][Full Text] [Related]
8. Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment.
Dugger BN; Davis K; Malek-Ahmadi M; Hentz JG; Sandhu S; Beach TG; Adler CH; Caselli RJ; Johnson TA; Serrano GE; Shill HA; Belden C; Driver-Dunckley E; Caviness JN; Sue LI; Jacobson S; Powell J; Sabbagh MN
BMC Neurol; 2015 Aug; 15():146. PubMed ID: 26289075
[TBL] [Abstract][Full Text] [Related]
9. AD lesions and infarcts in demented and non-demented Japanese-American men.
Petrovitch H; Ross GW; Steinhorn SC; Abbott RD; Markesbery W; Davis D; Nelson J; Hardman J; Masaki K; Vogt MR; Launer L; White LR
Ann Neurol; 2005 Jan; 57(1):98-103. PubMed ID: 15562458
[TBL] [Abstract][Full Text] [Related]
10. Pathology of clinical and preclinical Alzheimer's disease.
Thal DR; von Arnim C; Griffin WS; Yamaguchi H; Mrak RE; Attems J; Upadhaya AR
Eur Arch Psychiatry Clin Neurosci; 2013 Nov; 263 Suppl 2():S137-45. PubMed ID: 24077890
[TBL] [Abstract][Full Text] [Related]
11. Lewy body pathology modifies risk factors for cerebral amyloid angiopathy when comorbid with Alzheimer's disease pathology.
Pillai JA; Bena J; Tousi B; Rothenberg K; Keene CD; Leverenz JB
Alzheimers Dement; 2024 Apr; 20(4):2564-2574. PubMed ID: 38353367
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
[TBL] [Abstract][Full Text] [Related]
13. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.
Newell KL; Hyman BT; Growdon JH; Hedley-Whyte ET
J Neuropathol Exp Neurol; 1999 Nov; 58(11):1147-55. PubMed ID: 10560657
[TBL] [Abstract][Full Text] [Related]
14. Association of Delirium With Cognitive Decline in Late Life: A Neuropathologic Study of 3 Population-Based Cohort Studies.
Davis DH; Muniz-Terrera G; Keage HA; Stephan BC; Fleming J; Ince PG; Matthews FE; Cunningham C; Ely EW; MacLullich AM; Brayne C;
JAMA Psychiatry; 2017 Mar; 74(3):244-251. PubMed ID: 28114436
[TBL] [Abstract][Full Text] [Related]
15. Recent update on the heterogeneity of the Alzheimer's disease spectrum.
Jellinger KA
J Neural Transm (Vienna); 2022 Jan; 129(1):1-24. PubMed ID: 34919190
[TBL] [Abstract][Full Text] [Related]
16. The neuropathological diagnosis of Alzheimer's disease: clinical-pathological studies.
Hyman BT
Neurobiol Aging; 1997; 18(4 Suppl):S27-32. PubMed ID: 9330982
[TBL] [Abstract][Full Text] [Related]
17. Neuropathological alterations in Alzheimer disease.
Serrano-Pozo A; Frosch MP; Masliah E; Hyman BT
Cold Spring Harb Perspect Med; 2011 Sep; 1(1):a006189. PubMed ID: 22229116
[TBL] [Abstract][Full Text] [Related]
18. Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations.
Jacobson SA; Morshed T; Dugger BN; Beach TG; Hentz JG; Adler CH; Shill HA; Sabbagh MN; Belden CM; Sue LI; Caviness JN; Hu C;
Parkinsonism Relat Disord; 2014 Sep; 20(9):1009-14. PubMed ID: 25027359
[TBL] [Abstract][Full Text] [Related]
19. Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series.
Geut H; Hepp DH; Foncke E; Berendse HW; Rozemuller JM; Huitinga I; van de Berg WDJ
Acta Neuropathol Commun; 2020 Mar; 8(1):39. PubMed ID: 32216828
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration.
Chai YL; Chong JR; Weng J; Howlett D; Halsey A; Lee JH; Attems J; Aarsland D; Francis PT; Chen CP; Lai MKP
Brain Pathol; 2019 Jan; 29(1):63-74. PubMed ID: 30051532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
